Imaging for early stage breast cancer

Less local treatment: where is the limit?

Side effects

Continuation of tamoxifen treatment after

adjuvant tamoxifen for 1–4 years may provide

Japanese breast cancer patients with better

HRQOL than by switching to anastrozole.

Ohsumi S, et al. Breast Cancer Res Treat. 2011;127:143–152